Creutzfeldt-Jakob disease: the need to widen the differential diagnosis

E T Walsh1, J Bishop-Miller, R J Coles

  • 1Department of Old Age Psychiatry, Gartnavael Royal Hospital, Glasgow.

Scottish Medical Journal
|February 21, 2002
PubMed

Insights

Creutzfeldt-Jacob Disease can mimic vascular dementia, presenting diagnostic challenges. Early consideration of this rare prion disease is crucial for accurate diagnosis in dementia cases.

Area of Science:

  • Neurology
  • Prion Diseases
  • Neurodegenerative Disorders

Background:

  • Vascular dementia is a common cause of cognitive decline.
  • Creutzfeldt-Jacob Disease (CJD) is a rare, fatal prion disease affecting the brain.
  • Differentiating between various dementia types can be clinically challenging.

Observation:

  • A 76-year-old woman initially presented with symptoms suggestive of vascular dementia.
  • Her clinical presentation evolved over time.
  • Diagnostic re-evaluation was necessary due to the progression of her condition.

Findings:

  • The patient's diagnosis was revised to Creutzfeldt-Jacob Disease in its advanced stages.
  • The chronic form of CJD can present insidiously, resembling other dementia syndromes.
  • This case highlights the importance of considering CJD in the differential diagnosis of dementia.

Implications:

  • Clinicians should maintain a high index of suspicion for CJD in patients with rapidly or unusually progressing dementia.
  • Accurate diagnosis of CJD, though challenging, is vital for patient management and epidemiological studies.
  • Further research into early diagnostic markers for CJD could improve patient outcomes.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...